These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 13925633)

  • 1. [Hyponatremia and hyperkalemia in an ascitic cirrhosis patient. Regression of these abnormalities after a digestive hemorrhage].
    VESIN P; VEYNE S; HIRSCH-MARIE H; CATTAN R
    Bull Mem Soc Med Hop Paris; 1962 Jan 2-Feb 26; 113():123-8. PubMed ID: 13925633
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible hyponatremia and azotemia in a patient with cirrhosis and ascites.
    GALAMBOS JT; WILKINSON HA
    Am J Dig Dis; 1962 Jul; 7():642-7. PubMed ID: 13896294
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatorenal syndrome: study of clinical characteristics in a large series.
    Bern MM
    South Med J; 1973 Jul; 66(7):775-8. PubMed ID: 4543096
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of renal impairment in Laennec's cirrhosis.
    Mullane JF; Gliedman ML
    Ann Surg; 1971 Dec; 174(6):892-901. PubMed ID: 5316206
    [No Abstract]   [Full Text] [Related]  

  • 5. Red cell sodium and potassium contents in liver cirrhosis.
    Astrup J; Prytz H; Thomsen AC; Westrup M
    Gastroenterology; 1980 Mar; 78(3):530-4. PubMed ID: 7351291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyponatremia in cirrhosis with ascites].
    Bronzi G; Orlando D; De Feudis L; Delle Monache G; Scudieri M; Sergiacomo L; Bernardi M; Pesa O
    Minerva Med; 1990 Sep; 81(9):591-6. PubMed ID: 2234478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypernatremia following gastrointestinal bleeding in cirrhosis with ascites.
    Rodés J; Arroyo V; Bordas JM; Bruguera M
    Am J Dig Dis; 1975 Feb; 20(2):127-33. PubMed ID: 1079110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The "elevation of kaliemia-azotemia-oliguria" syndrome in ascitic cirrhosis. Mechanism and therapeutic results (failure of spirolactones)].
    VESIN P; GIBOUDEAU ; RENAULT H; CATTAN R
    Bull Mem Soc Med Hop Paris; 1960 Oct 14-21; 76():1013-21. PubMed ID: 13781051
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyponatremic syndrome after salt-free diet, enforced diuresis and/or paracentesis for ascites in chronic liver insufficiency; hyponatremia, hypochloremia, hyperkalemia and azotemia].
    MARTINI GA; RAUSCH-STROOMANN JG
    Klin Wochenschr; 1959 Apr; 37(7):385-94. PubMed ID: 13642774
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of the serum electrolytes sodium and potassium in patients with cholelithiasis with reference to pathologic changes in the liver].
    Schmauss AK; Gerloff D; Poley FW
    Z Gesamte Inn Med; 1971 May; 26(10):327-31. PubMed ID: 5131401
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and prognostic significance of hyperkalemia in hospitalized patients with cirrhosis.
    Maiwall R; Kumar S; Sharma MK; Wani Z; Ozukum M; Sarin SK
    J Gastroenterol Hepatol; 2016 May; 31(5):988-94. PubMed ID: 26598065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
    Ginès P; Wong F; Watson H; Milutinovic S; del Arbol LR; Olteanu D;
    Hepatology; 2008 Jul; 48(1):204-13. PubMed ID: 18508290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.
    Gerbes AL; Gülberg V; Ginès P; Decaux G; Gross P; Gandjini H; Djian J;
    Gastroenterology; 2003 Apr; 124(4):933-9. PubMed ID: 12671890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.
    Nguyen-Khac E; Thevenot T; Capron D; Dharancy S; Paupart T; Thabut D; Tiry C
    Eur J Intern Med; 2008 Dec; 19(8):613-8. PubMed ID: 19046728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis.
    Cárdenas A; Ginès P; Marotta P; Czerwiec F; Oyuang J; Guevara M; Afdhal NH
    J Hepatol; 2012 Mar; 56(3):571-8. PubMed ID: 22027579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related variety in electrolyte levels and prevalence of dysnatremias and dyskalemias in patients presenting to the emergency department.
    Lindner G; Pfortmüller CA; Leichtle AB; Fiedler GM; Exadaktylos AK
    Gerontology; 2014; 60(5):420-3. PubMed ID: 24854398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LIMITS OF TREATMENT OF CIRRHOSIS WITH DIURETICS (SALDIURETICS AND ALDOSTERONE ANTAGONISTS)].
    ALBEAUX-FERNET M; ROMANI JD
    Bull Mem Soc Med Hop Paris; 1963 Nov; 114():1277-84. PubMed ID: 14098211
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of ascites.
    Stassen WN; McCullough AJ
    Semin Liver Dis; 1985 Aug; 5(3):291-307. PubMed ID: 3901276
    [No Abstract]   [Full Text] [Related]  

  • 19. Peritoneal dialysis in hyponatremia due to liver failure.
    Ring-Larsen H; Clausen E; Ranek L
    Scand J Gastroenterol; 1973; 8(1):33-40. PubMed ID: 4697064
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyponatremia and hyperkalemia associated with chylous pleural and peritoneal effusion in a cat.
    Thompson MD; Carr AP
    Can Vet J; 2002 Aug; 43(8):610-3. PubMed ID: 12170837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.